
- •Preface
- •List of contributers
- •History, epidemiology, prevention and education
- •A history of burn care
- •“Black sheep in surgical wards”
- •Toxaemia, plasmarrhea, or infection?
- •The Guinea Pig Club
- •Burns and sulfa drugs at Pearl Harbor
- •Burn center concept
- •Shock and resuscitation
- •Wound care and infection
- •Burn surgery
- •Inhalation injury and pulmonary care
- •Nutrition and the “Universal Trauma Model”
- •Rehabilitation
- •Conclusions
- •References
- •Epidemiology and prevention of burns throughout the world
- •Introduction
- •Epidemiology
- •The inequitable distribution of burns
- •Cost by age
- •Cost by mechanism
- •Limitations of data
- •Risk factors
- •Socioeconomic factors
- •Race and ethnicity
- •Age-related factors: children
- •Age-related factors: the elderly
- •Regional factors
- •Gender-related factors
- •Intent
- •Comorbidity
- •Agents
- •Non-electric domestic appliances
- •War, mass casualties, and terrorism
- •Interventions
- •Smoke detectors
- •Residential sprinklers
- •Hot water temperature regulation
- •Lamps and stoves
- •Fireworks legislation
- •Fire-safe cigarettes
- •Children’s sleepwear
- •Acid assaults
- •Burn care systems
- •Role of the World Health Organization
- •Conclusions and recommendations
- •Surveillance
- •Smoke alarms
- •Gender inequality
- •Community surveys
- •Acknowledgements
- •References
- •Prevention of burn injuries
- •Introduction
- •Burns prevalence and relevance
- •Burn injury risk factors
- •WHERE?
- •Burn prevention types
- •Burn prevention: The basics to design a plan
- •Flame burns
- •Prevention of scald burns
- •Conclusions
- •References
- •Burns associated with wars and disasters
- •Introduction
- •Wartime burns
- •Epidemiology of burns sustained during combat operations
- •Fluid resuscitation and initial burn care in theater
- •Evacuation of thermally-injured combat casualties
- •Care of host-nation burn patients
- •Disaster-related burns
- •Epidemiology
- •Treatment of disaster-related burns
- •The American Burn Association (ABA) disaster management plan
- •Summary
- •References
- •Education in burns
- •Introduction
- •Surgical education
- •Background
- •Simulation
- •Education in the internet era
- •Rotations as courses
- •Mentorship
- •Peer mentorship
- •Hierarchical mentorship
- •What is a mentor
- •Implementation
- •Interprofessional education
- •What is interprofessional education
- •Approaches to interprofessional education
- •References
- •European practice guidelines for burn care: Minimum level of burn care provision in Europe
- •Foreword
- •Background
- •Introduction
- •Burn injury and burn care in general
- •Conclusion
- •References
- •Pre-hospital and initial management of burns
- •Introduction
- •Modern care
- •Early management
- •At the accident
- •At a local hospital – stabilization prior to transport to the Burn Center
- •Transportation
- •References
- •Medical documentation of burn injuries
- •Introduction
- •Medical documentation of burn injuries
- •Contents of an up-to-date burns registry
- •Shortcomings in existing documentation systems designs
- •Burn depth
- •Burn depth as a dynamic process
- •Non-clinical methods to classify burn depth
- •Burn extent
- •Basic principles of determining the burn extent
- •Methods to determine burn extent
- •Computer aided three-dimensional documentation systems
- •Methods used by BurnCase 3D
- •Creating a comparable international database
- •Results
- •Conclusion
- •Financing and accomplishment
- •References
- •Pathophysiology of burn injury
- •Introduction
- •Local changes
- •Burn depth
- •Burn size
- •Systemic changes
- •Hypovolemia and rapid edema formation
- •Altered cellular membranes and cellular edema
- •Mediators of burn injury
- •Hemodynamic consequences of acute burns
- •Hypermetabolic response to burn injury
- •Glucose metabolism
- •Myocardial dysfunction
- •Effects on the renal system
- •Effects on the gastrointestinal system
- •Effects on the immune system
- •Summary and conclusion
- •References
- •Anesthesia for patients with acute burn injuries
- •Introduction
- •Preoperative evaluation
- •Monitors
- •Pharmacology
- •Postoperative care
- •References
- •Diagnosis and management of inhalation injury
- •Introduction
- •Effects of inhaled gases
- •Carbon monoxide
- •Cyanide toxicity
- •Upper airway injury
- •Lower airway injury
- •Diagnosis
- •Resuscitation after inhalation injury
- •Other treatment issues
- •Prognosis
- •Conclusions
- •References
- •Respiratory management
- •Airway management
- •(a) Endotracheal intubation
- •(b) Elective tracheostomy
- •Chest escharotomy
- •Conventional mechanical ventilation
- •Introduction
- •Pathophysiological principles
- •Low tidal volume and limited plateau pressure approaches
- •Permissive hypercapnia
- •The open-lung approach
- •PEEP
- •Lung recruitment maneuvers
- •Unconventional mechanical ventilation strategies
- •High-frequency percussive ventilation (HFPV)
- •High-frequency oscillatory ventilation
- •Airway pressure release ventilation (APRV)
- •Ventilator associated pneumonia (VAP)
- •(a) Prevention
- •(b) Treatment
- •References
- •Organ responses and organ support
- •Introduction
- •Burn shock and resuscitation
- •Post-burn hypermetabolism
- •Individual organ systems
- •Central nervous system
- •Peripheral nervous system
- •Pulmonary
- •Cardiovascular
- •Renal
- •Gastrointestinal tract
- •Conclusion
- •References
- •Critical care of thermally injured patient
- •Introduction
- •Oxidative stress control strategies
- •Fluid and cardiovascular management beyond 24 hours
- •Other organ function/dysfunction and support
- •The nervous system
- •Respiratory system and inhalation injury
- •Renal failure and renal replacement therapy
- •Gastro-intestinal system
- •Glucose control
- •Endocrine changes
- •Stress response (Fig. 2)
- •Low T3 syndrome
- •Gonadal depression
- •Thermal regulation
- •Metabolic modulation
- •Propranolol
- •Oxandrolone
- •Recombinant human growth hormone
- •Insulin
- •Electrolyte disorders
- •Sodium
- •Chloride
- •Calcium, phosphate and magnesium
- •Calcium
- •Bone demineralization and osteoporosis
- •Micronutrients and antioxidants
- •Thrombosis prophylaxis
- •Conclusion
- •References
- •Treatment of infection in burns
- •Introduction
- •Clinical management strategies
- •Pathophysiology of the burn wound
- •Burn wound infection
- •Cellulitis
- •Impetigo
- •Catheter related infections
- •Urinary tract infection
- •Tracheobronchitis
- •Pneumonia
- •Sepsis in the burn patient
- •The microbiology of burn wound infection
- •Sources of organisms
- •Gram-positive organisms
- •Gram-negative organisms
- •Infection control
- •Pharmacological considerations in the treatment of burn infections
- •Topical antimicrobial treatment
- •Systemic antimicrobial treatment (Table 3)
- •Gram-positive bacterial infections
- •Enterococcal bacterial infections
- •Gram-negative bacterial infections
- •Treatment of yeast and fungal infections
- •The Polyenes (Amphotericin B)
- •Azole antifungals
- •Echinocandin antifungals
- •Nucleoside analog antifungal (Flucytosine)
- •Conclusion
- •References
- •Acute treatment of severely burned pediatric patients
- •Introduction
- •Initial management of the burned child
- •Fluid resuscitation
- •Sepsis
- •Inhalation injury
- •Burn wound excision
- •Burn wound coverage
- •Metabolic response and nutritional support
- •Modulation of the hormonal and endocrine response
- •Recombinant human growth hormone
- •Insulin-like growth factor
- •Oxandrolone
- •Propranolol
- •Glucose control
- •Insulin
- •Metformin
- •Novel therapeutic options
- •Long-term responses
- •Conclusion
- •References
- •Adult burn management
- •Introduction
- •Epidemiology and aetiology
- •Pathophysiology
- •Assessment of the burn wound
- •Depth of burn
- •Size of the burn
- •Initial management of the burn wound
- •First aid
- •Burn blisters
- •Escharotomy
- •General care of the adult burn patient
- •Biological/Semi biological dressings
- •Topical antimicrobials
- •Biological dressings
- •Other dressings
- •Exposure
- •Deep partial thickness wound
- •Total wound excision
- •Serial wound excision and conservative management
- •Full thickness burns
- •Excision and autografting
- •Topical antimicrobials
- •Large full thickness burns
- •Serial excision
- •Mixed depth burn
- •Donor sites
- •Techniques of wound excision
- •Blood loss
- •Antibiotics
- •Anatomical considerations
- •Skin replacement
- •Autograft
- •Allograft
- •Other skin replacements
- •Cultured skin substitutes
- •Skin graft take
- •Rehabilitation and outcome
- •Future care
- •References
- •Burns in older adults
- •Introduction
- •Burn injury epidemiology
- •Pathophysiologic changes and implications for burn therapy
- •Aging
- •Comorbidities
- •Acute management challenges
- •Fluid resuscitation
- •Burn excision
- •Pain and sedation
- •End of life decisions
- •Summary of key points and recommendations
- •References
- •Acute management of facial burns
- •Introduction
- •Anatomy and pathophysiology
- •Management
- •General approach
- •Airway management
- •Facial burn wound management
- •Initial wound care
- •Topical agents
- •Biological dressings
- •Surgical burn wound excision of the face
- •Wound closure
- •Special areas and adjacent of the face
- •Eyelids
- •Nose and ears
- •Lips
- •Scalp
- •The neck
- •Catastrophic injury
- •Post healing rehabilitation and scar management
- •Outcome and reconstruction
- •Summary
- •References
- •Hand burns
- •Introduction
- •Initial evaluation and history
- •Initial wound management
- •Escharotomy and fasciotomy
- •Surgical management: Early excision and grafting
- •Skin substitutes
- •Amputation
- •Hand therapy
- •Secondary reconstruction
- •References
- •Treatment of burns – established and novel technology
- •Introduction
- •Partial thickness burns
- •Biological membranes – amnion and others
- •Xenograft
- •Full thickness burns
- •Dermal analogs
- •Keratinocyte coverage
- •Facial transplantation
- •Tissue engineering and stem cells
- •Gene therapy and growth factors
- •Conclusion
- •References
- •Wound healing
- •History of wound care
- •Types of wounds
- •Mechanisms of wound healing
- •Hemostasis
- •Proliferation
- •Epithelialization
- •Remodeling
- •Fetal wound healing
- •Stem cells
- •Abnormal wound healing
- •Impaired wound healing
- •Hypertrophic scars and keloids
- •Chronic non-healing wounds
- •Conclusions
- •References
- •Pain management after burn trauma
- •Introduction
- •Pathophysiology of pain after burn injuries
- •Nociceptive pain
- •Neuropathic pain
- •Sympathetically Maintained Pain (SMP)
- •Pain rating and documentation
- •Pain management and analgesics
- •Pharmacokinetics in severe burns
- •Form of administration [21]
- •Non-opioids (Table 1)
- •Paracetamol
- •Metamizole
- •Non-steroidal antirheumatics (NSAID)
- •Selective cyclooxygenasis-2-inhibitors
- •Opioids (Table 2)
- •Weak opioids
- •Strong opioids
- •Other analgesics
- •Ketamine (see also intensive care unit and analgosedation)
- •Anticonvulsants (Gabapentin and Pregabalin)
- •Antidepressants with analgesic effects
- •Regional anesthesia
- •Pain management without analgesics
- •Adequate communication
- •Psychological techniques [65]
- •Transcutaneous electrical nerve stimulation (TENS)
- •Particularities of burn pain
- •Wound pain
- •Breakthrough pain
- •Intervention-induced pain
- •Necrosectomy and skin grafting
- •Dressing change of large burn wounds and removal of clamps in skin grafts
- •Dressing change in smaller burn wounds, baths and physical therapy
- •Postoperative pain
- •Mental aspects
- •Intensive care unit
- •Opioid-induced hyperalgesia and opioid tolerance
- •Hypermetabolism
- •Psychic stress factors
- •Risk of infection
- •Monitoring [92]
- •Sedation monitoring
- •Analgesia monitoring (see Fig. 2)
- •Analgosedation (Table 3)
- •Sedation
- •Analgesia
- •References
- •Nutrition support for the burn patient
- •Background
- •Case presentation
- •Patient selection: Timing and route of nutritional support
- •Determining nutritional demands
- •What is an appropriate initial nutrition plan for this patient?
- •Formulations for nutritional support
- •Monitoring nutrition support
- •Optimal monitoring of nutritional status
- •Problems and complications of nutritional support
- •Conclusion
- •References
- •HBO and burns
- •Historical development
- •Contraindications for the use of HBO
- •Conclusion
- •References
- •Nursing management of the burn-injured person
- •Introduction
- •Incidence
- •Prevention
- •Pathophysiology
- •Severity factors
- •Local damage
- •Fluid and electrolyte shifts
- •Cardiovascular, gastrointestinal and renal system manifestations
- •Types of burn injuries
- •Thermal
- •Chemical
- •Electrical
- •Smoke and inhalation injury
- •Clinical manifestations
- •Subjective symptoms
- •Possible complications
- •Clinical management
- •Non-surgical care
- •Surgical care
- •Coordination of care: Burn nursing’s unique role
- •Nursing interventions: Emergent phase
- •Nursing interventions: Acute phase
- •Nursing interventions: Rehabilitative phase
- •Ongoing care
- •Infection prevention and control
- •Rehabilitation medicine
- •Nutrition
- •Pharmacology
- •Conclusion
- •References
- •Outpatient burn care
- •Introduction
- •Epidemiology
- •Accident causes
- •Care structures
- •Indications for inpatient treatment
- •Patient age
- •Total burned body surface area (TBSA)
- •Depth of the burn
- •Pre-existing conditions
- •Accompanying injuries
- •Special injuries
- •Treatment
- •Initial treatment
- •Pain therapy
- •Local treatment
- •Course of treatment
- •Complications
- •Infections
- •Follow-up care
- •References
- •Non-thermal burns
- •Electrical injury
- •Introduction
- •Pathophysiology
- •Initial assessment and acute care
- •Wound care
- •Diagnosis
- •Low voltage injuries
- •Lightning injuries
- •Complications
- •References
- •Symptoms, diagnosis and treatment of chemical burns
- •Chemical burns
- •Decontamination
- •Affection of different organ systems
- •Respiratory tract
- •Gastrointestinal tract
- •Hematological signs
- •Nephrologic symptoms
- •Skin
- •Nitric acid
- •Sulfuric acid
- •Caustic soda
- •Phenol
- •Summary
- •References
- •Necrotizing and exfoliative diseases of the skin
- •Introduction
- •Necrotizing diseases of the skin
- •Cellulitis
- •Staphylococcal scalded skin syndrome
- •Autoimmune blistering diseases
- •Epidermolysis bullosa acquisita
- •Necrotizing fasciitis
- •Purpura fulminans
- •Exfoliative diseases of the skin
- •Stevens-Johnson syndrome
- •Toxic epidermal necrolysis
- •Conclusion
- •References
- •Frostbite
- •Mechanism
- •Risk factors
- •Causes
- •Diagnosis
- •Treatment
- •Rewarming
- •Surgery
- •Sympathectomy
- •Vasodilators
- •Escharotomy and fasciotomy
- •Prognosis
- •Research
- •References
- •Subject index

Outpatient burn care
Delayed wound healing
In most cases, superficial wounds usually heal within a period of up to three weeks without any further consequences. If healing occurs without any complications, one should not expect the formation of excessive scars and the resulting functional and aesthetic effects. If during the course of treatment, the physician ascertains that the wound is healing slowly or not at all without any epithelialization, and instead discovers the formation of granulation tissue, the patient should be admitted to a specialized facility. Incorrect diagnoses during the primary evaluation, the wound deepening due to toxic substances in the dressing, and an infection can all cause the aforementioned to occur. Depending on the location and extent of the wound, the selected treatment regime should be changed. It may be necessary to remove the granulation tissue and/or remaining necrotic tissue once again, with subsequent skin grafting. In individual cases, the use of a keratinocyte cell spray to close the wound has proven to be successful, particularly when dealing with partial-thick- ness wounds [35].
It is important to know that if the wound does not heal, the treatment regime must be changed in order to achieve the best healing results for the patient.
Follow-up care
Patients with burn wounds that receive outpatient treatment still require adequate follow-up care after the epithelialization process is complete. This includes providing the patient with extensive information regarding the further course of action [36]. The patient should avoid applying shear force to the area of the former wound, since this could result in the formation of new tension blisters. In addition, depending on the type and dryness of the patient’s skin, it is recommended that they apply lubricant to the formerly burned area [37]. Systematically protecting the area from UV rays should also be recommended to the patient. Besides avoiding exposure, this can be achieved through the use of suntan lotion with an SPF around 30.
Since the focus of outpatient burn care is on superficial burn wounds, additional follow-up care
methods using silicone gel sheets and/or compression bandages will not be discussed here in detail. However, if hypertrophic scars do form after a burn victim receives outpatient care, these products should be used as described in another section of this book.
References
[1]Brigham PA, McLoughlin E (1996) Burn incidence and medical care use in the United States: estimates, trends and data sources. J Burn Care Rehabil 17: 169–171
[2]Burd A, Yuen C (2005) A global study of hospitalized burn patients. Burns 31(4): 432–438
[3]Statistisches Bundesamt. Todesursachen in Deutschland 2004 (Fachserie 12/ Reihe 4) Wiesbaden 2006
[4]Blome-Eberwein S, Jester A, Küntscher M, Germann G (2001) Besonderheiten in der Erstversorgung von Brandverletzten. Akt Traumatol 31: 201–204
[5]Germann G, Barthold U, Lefering R, Raff T, Hartmann B (1997) The impact of risk factors and pre-existing conditions on the mortality of burn patients and the precision of predictive admission-scoring systems. Burns 23(3): 195–203
[6]Hartford CE, Kealy GP (2007) Care of outpatient burns. In: Herndon DN (ed) Total burne care, 3rd edn. Saunders Elsevier
[7]Tobiasen J, Hiebert JH, Edlich RF (1982) Prediction of burn mortality. Surg Gynecol Obstet 154(5): 711–714
[8]Smith DL, Cairns BA, Ramadan F, Rutledge R et al (1994) Effect of inhalation injury, burn size and age on mortality: a study of 1447 consecutive burn patients. J Trauma 37(4): 655–659
[9]O’Keefe GE, Hunt JL, Purdue GF (2001) An evaluation of risk factors for mortality after burn trauma and the identification of gender-dependent differences in outcomes. J Am Coll 192(2): 153–160
[10]Raff T, Germann G, Barthold U (1996) Factors influencing the early prediction of outcome from burns. Acta Chir Plast 38(4): 122–127
[11]Muller MJ, Pegg SP, Rule MR (2001) Determinants of death following burn injury. Br J Surg 88(4): 583–587
[12]Wachtel TL et al (1986) B-mode ultrasonic echo determination of depth of thermal injury. Burns 12: 432–437
[13]Groeneveld AB (1990) Septic shock and multiple organ failure. Int Care Med 16: 489–490
[14]Lavrentieva A, Kontakiotis T Lazaridis L et al (2008) Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis? Burns 33(2): 1 89–94
[15]Atiyeh BS, Gunn SW, Hayek SN (2005) State of the art in burn treatment. World J Surg 29(2): 131–148
[16]Brusselaers N, Hoste EA, Monstrey S et al (2006) Outcome and changes over time in survival following severe burns from 1985 to 2004. Intensive Care Med 31(12): 1648–1653
439

B. Hartmann, Ch. Ottomann
[17]Artuson MG (1985) The pathophysiology of severe thermal injury. J Burn Care Rehabil 6: 129
[18]Wittram C, Kenny JB (1994) The admission chest radiopraph after acute inhalation injury and burns. Br J Radiol 67: 751–754
[19]Schultz JH, Schmidt HG, Queitsch C et al (1995) Die Behandlung schwerer Begleitverletzungen beim Verbrennungspatienten. Unfallchirurg (98): 224–228
[20]Kildal M, Willebrand M, Andersson G et al (2005) Coping strategies, injury characteristics and long-term outcome after burn injury. Injury 36(4): 511–518
[21]Dokov W (2009) Assessment of risk factors for death in electrical injury. Burns 35: 114–117
[22]Burd A, Ahmed K (2010) The acute management of acid assault burns. Ind J Plast Surg 43(1): 29–33
[23]Theodorou P, Phan V, Weinand C et al (2011) Suicide by Burning: Epidemiological and Clinical Profile. Ann Surg 10: 204
[24]Cross KM, Leonardi L, Fish JS et al (2009) Noninvasive measurement of edema in partial thickness burn wounds. J Burn Care Res 30(5): 807–817
[25]Lund T, Onarheim H, Reed RK (1992) Pathogenesis of endema formation in burn injuries. World J Surg 16: 2
[26]Browne Al, Andrews R, Wood F (2011) Persistant pain outcomes and patient satisfaction with pain management after burn injury. Clin J Pain 27(2): 136–145
[27]Burton F (2004) An evaluation of non-adherent woundcontact layers for acute traumatic and surgical wounds. J Wound Care 13(9): 371–373
[29]Sörensen R, Fisker NP, Steensen JP (1984) Acuta excision of exposure treatment? Final results of a threeyear randomised controlled clinical trial. Scan J Plast Reconstr Surg 8: 87–93
[30]Pallua N, von Bülow S (2006) Behandlungskonzepte bei Verbrennungen. Teil II: Technische Aspekte. Chirurg 77(2): 179–186
[31]Costagliola M, Agrosi M (2005) Second-degree burns: a comparative, multicenter, randomized trial of hyaluronic acid plus silver sulfadiazine vs. silver sulfadiazine alone. Curr Med Res Opin 21(8): 1235–1240
[32]Daeschlein G, Assadian O, Koch S et al (2007) Feasibility and clinical applicability of polihexanide for treatment of second-degree burn wounds. Skin Pharm Phys 20(6): 292–296
[33]Wilder D, Rennekampff HO (2007) Debridement of burn wounds – rationale and options. Hamipla 39(5): 302–307
[34]Philipp K, Gazyakan E, Germann G, Öhlbauer M (2005) Von der Erstversorgung bis zur Plastischen Chirurgie – Spezielle Behandlungsaspekte bei Verbrennungen. Klinikarzt 34: 249–254
[35]Enoch S, Grey JE, Harding KG (2006) ABC of wound healing: Recent advances and emerging treatments. BMJ 332(7547): 962–965
[36]Acton A, Mounsey E, Gilyard C (2007) The burn survivor perspective. J Burn C Res 28(4): 615–620
[37]Chapman TT (2007) Burn scar and contracture management. J Trauma 62(6): 8
[28]Mozingo DW, McManus AT, Kim SH, Pruitt BA (1997) Correspondence: Dr. med. Bernd Hartmann, Zentrum für
Incidence of bacteremia after burn wound manipu- |
Schwerbrandverletzte mit Plastischer Chirurgie, Unfallkran- |
lation in the early postburn period. J Trauma 42: |
kenhaus Berlin, Warener Straße 7, 12683 Berlin, Germany, |
1006–1010 |
E-mail: bernd.hartmann@ukb.de |
440